Midjourney's Spa Ultrasound Tank Wows With Ambition But Offers Little Clinical Proof
Key takeaways
- Midjourney's full-body ultrasound scanner was described by a company engineer as repurposed probes on a 'glorified hot tub,' raising questions about clinical-grade reliability.
- The behind-the-scenes video shows imaging of laboratory phantoms rather than real human anatomy, offering limited proof of real-world diagnostic performance.
- No peer-reviewed studies, regulatory filings, or independent clinical assessments of the device have been made public, leaving its medical viability unverified.
Midjourney, the AI startup that made its name generating synthetic imagery, is doubling down on an unlikely pivot: a full-body ultrasound scanner it envisions deploying in spas and wellness centers. The company recently released a nearly 20-minute behind-the-scenes video tour of the device, hosted by tech YouTuber Marcin Plaza, who is also an engineer at the company. The video is the most detailed public look yet at the hardware, but it raises as many questions as it answers about the scanner's real-world medical viability.
Plaza's own description of the machine is disarmingly candid. He characterizes the contraption as scores of ultrasound probes that have been 'hacked apart and slapped on a glorified hot tub with an elevator in it,' all wired into off-the-shelf computers and Raspberry Pi components. That level of transparency is refreshing in a landscape where medical device startups often shroud their hardware in mystique, but it also highlights just how far the device sits from the polished, rigorously validated equipment typically found in clinical settings.
The scanner is designed to be radiation-free, cheap to operate, and accessible enough for spa environments — a significant departure from hospital-grade imaging. Midjourney's pitch is that democratizing detailed body scans could transform preventive medicine, catching conditions earlier and without the cost barriers of traditional MRI or CT imaging. It is an appealing vision, and the company's AI background theoretically positions it well to process and interpret the large volumes of imaging data such a scanner would generate.
However, the video tour notably sidesteps the harder questions around clinical validation. Images shown in accompanying materials depict scans of imaging phantoms — controlled laboratory stand-ins designed to test how cleanly a device can separate structures under ideal conditions. Phantoms are a legitimate starting point in device development, but they are a long way from demonstrating consistent, accurate performance on real human anatomy across diverse body types and physiological conditions.
Midjourney has not publicly shared peer-reviewed data, regulatory filings, or third-party clinical assessments of the scanner's diagnostic accuracy. For a device the company wants positioned in consumer wellness spaces, that evidentiary gap is significant. Medical regulators in the United States and Europe require rigorous demonstration of safety and efficacy before imaging devices can be marketed with clinical claims, and the current public record gives little insight into where Midjourney stands in that process.
The bigger picture
Midjourney's scanner project is a fascinating case study in what happens when a software-native AI company attempts to leap into medical hardware. The company built enormous credibility and a loyal user base through image generation, and that brand equity is now being leveraged to generate buzz around an entirely different product category. That strategy can work — Apple's move into health monitoring is the obvious precedent — but hardware development, especially in regulated medical contexts, operates on a fundamentally different timeline and risk profile than shipping software updates.
The competitive implications are worth watching carefully. If Midjourney's scanner even partially delivers on its promise, it could pressure established ultrasound manufacturers who have long relied on the complexity and cost of their devices as a moat. Companies like GE HealthCare, Philips, and Fujifilm have invested decades in probe design, image processing algorithms, and clinical relationships. A credible low-cost alternative distributed through consumer wellness channels would force them to defend market segments they have historically ignored. That disruption scenario is real — but it requires Midjourney to first clear the formidable hurdle of regulatory approval and clinical trust-building.
What observers should watch next is whether the company moves toward transparent clinical partnerships and regulatory engagement, or continues to operate in a demonstration-and-hype mode. The difference matters enormously. Releasing polished videos is relatively cheap; funding proper clinical trials, navigating FDA 510(k) pathways or CE marking processes, and building relationships with radiologists and clinicians is expensive, slow, and unglamorous. Midjourney's willingness — or reluctance — to pursue those steps will determine whether this scanner becomes a genuine medical tool or remains a compelling but ultimately hollow prototype.
We decided to cover this story because it sits at a genuinely interesting and underexamined intersection of AI hype, consumer wellness culture, and the hard realities of medical device development. At LagPing, we think it is important to give our readers the full picture when a high-profile tech brand makes claims that touch on health and medicine — areas where the stakes of overpromising are far higher than in a typical software product launch. Midjourney is a company we have watched closely, and this pivot deserves scrutiny rather than just amplification. The questions left unanswered by the video are arguably more newsworthy than the footage itself. We will continue following this story as regulatory details, clinical evidence, or independent testing emerges — because the gap between a compelling demo and a validated medical device is exactly the kind of thing our readers deserve to understand.
As an Amazon Associate, LagPing earns from qualifying purchases. Product links are affiliate links.
You might also like
Dataminers Uncover Cut COD: WaW Feature That Would've Let Players Call In Customizable Tanks
1d ago
Ex-Destiny and League Devs Unveil Tyr: A Tank Shooter Where Staying Hidden Beats Staying Alive
Jul 30
Rebel Wolves' Vampire RPG Wows Critics in Early Hands-On: A Witcher Rival in the Making?
Jul 9
Roku Launches Around-the-Clock AI Content Channel Amid Growing FAST Debate
18h ago